Glucosamine modulates T cell differentiation through down-regulating N-linked glycosylation of CD25

Journal of Biological Chemistry

Volumn 290, Issue 49, 2015, Pages 29329-29344

  Chien, Ming Wei ^a   Lin, Ming Hong ^a   Huang, Shing Hwa ^a   Fu, Shin Huei ^a   Hsu, Chao Yuan ^a   Yen, B Lin Ju ^b   Chen, Jiann Torng ^a   Chang, Deh Ming ^a   Sytwu, Huey Kang ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SIGNALING; CELLS; CYTOLOGY; GLUCOSAMINE; GLUCOSE; GLYCOSYLATION; SIGNALING;

AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; DOSE-DEPENDENT MANNER; HIGH DOSE; IMMUNOMODULATORY EFFECTS; N-GLYCOSYLATION; N-LINKED GLYCOSYLATION; POLARIZED CELLS;

T-CELLS;

GLUCOSAMINE; GLUCOSE; GLUCOSE TRANSPORTER 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; STAT5 PROTEIN; SLC2A1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; DRUG MECHANISM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GLYCOLYSIS; GRAFT SURVIVAL; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; AUTOIMMUNE DISEASE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; GLYCOSYLATION; LYMPHOCYTE ACTIVATION; METABOLISM; NONOBESE DIABETIC MOUSE; SCID MOUSE; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DOWN-REGULATION; FEMALE; GLUCOSAMINE; GLUCOSE TRANSPORTER TYPE 1; GLYCOSYLATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84949009156     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.674671     Document Type: Article

References (60)

1. O'Shea, J. J., and Paul, W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102
2. Minami, Y., Kono, T., Miyazaki, T., and Taniguchi, T. (1993) The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11, 245-268
3. Katz, J. D., Wang, B., Haskins, K., Benoist, C., and Mathis, D. (1993) Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089-1100
4. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., and Sakaguchi, S. (1998) Immunologic self-tolerance maintained by CD25-CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980
5. Liao, W., Lin, J. X., and Leonard, W. J. (2011) IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin. Immunol. 23, 598-604
6. Kelly, E., Won, A., Refaeli, Y., and Van Parijs, L. (2002) IL-2 and related cytokines can promote T cell survival by activating AKT. J. Immunol. 168, 597-603
7. Moon, J. J., Rubio, E. D., Martino, A., Krumm, A., and Nelson, B. H. (2004) A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. J. Biol. Chem. 279, 5520-5527
8. Moriggl, R., Topham, D. J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M. Y., Bunting, K. D., Grosveld, G. C., and Ihle, J. N. (1999) Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10, 249-259
9. Lockyer, H. M., Tran, E., and Nelson, B. H. (2007) STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. J. Immunol. 179, 5301-5308
10. Cote-Sierra, J., Foucras, G., Guo, L., Chiodetti, L., Young, H. A., Hu-Li, J., Zhu, J., and Paul, W. E. (2004) Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. U.S.A. 101, 3880-3885
11. Liao, W., Schones, D. E., Oh, J., Cui, Y., Cui, K., Roh, T. Y., Zhao, K., and Leonard, W. J. (2008) Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptorβ-chain expression. Nat. Immunol. 9, 1288-1296
12. Liao, W., Lin, J. X., Wang, L., Li, P., and Leonard, W. J. (2011) Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 12, 551-559
13. Miller, A. T., and Berg, L. J. (2002) Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase. J. Immunol. 168, 2163-2172
14. Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., Shevach, E. M., and O'Shea, J, J. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381
15. Chen, Q., Kim, Y. C., Laurence, A., Punkosdy, G. A., and Shevach, E. M. (2011) IL-2 controls the stability of Foxp3 expression in TGF-β-induced Foxp3 T cells in vivo. J. Immunol. 186, 6329-6337
16. Ma, L., Rudert, W. A., Harnaha, J., Wright, M., Machen, J., Lakomy, R., Qian, S., Lu, L., Robbins, P. D., Trucco, M., and Giannoukakis, N. (2002) Immunosuppressive effects of glucosamine. J. Biol. Chem. 277, 39343-39349
17. Forchhammer, L., Thorn, M., Met, O., Gad, M., Weidner, M. S., and Claesson, M. H. (2003) Immunobiological effects of glucosamine in vitro. Scand. J. Immunol. 58, 404-411
18. Zhang, G. X., Yu, S., Gran, B., and Rostami, A. (2005) Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response. J. Immunol. 175, 7202-7208
19. Kim, C. H., Cheong, K. A., Park, C. D., and Lee, A. Y. (2011) Glucosamine improved atopic dermatitis-like skin lesions in NC/Nga mice by inhibition of Th2 cell development. Scand J. Immunol. 73, 536-545
20. Klenk, H. D., Scholtissek, C., and Rott, R. (1972) Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology 49, 723-734
21. Chen, C. L., Liang, C. M., Chen, Y. H., Tai, M. C., Lu, D. W., and Chen, J. T. (2012) Glucosamine modulates TNF-β-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 53, 2281-2291
22. Grigorian, A., Lee, S. U., Tian, W., Chen, I. J., Gao, G., Mendelsohn, R., Dennis, J. W., and Demetriou, M. (2007) Control of T Cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis. J. Biol. Chem. 282, 20027-20035
23. Demetriou, M., Granovsky, M., Quaggin, S., and Dennis, J. W. (2001) NegativeregulationofT-cellactivationandautoimmunitybyMgat5N-glycosylation. Nature 409, 733-739
24. Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., and Dennis, J. W. (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129, 123-134
25. Morgan, R., Gao, G., Pawling, J., Dennis, J. W., Demetriou, M., and Li, B. (2004) N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J. Immunol. 173, 7200-7208
26. Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., and Dennis, J. W. (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306, 120-124
27. Malek, T. R., Ashwell, J. D., Germain, R. N., Shevach, E. M., and Miller, J. (1986) The murine interleukin-2 receptor: biochemical structure and regulation of expression. Immunol. Rev. 92, 81-101
28. Semmes, O. J., Sztein, M. S., Bailey, J. M., and Merritt, W. D. (1992) Tunicamycin inhibits function and expression of the high-affinity IL-2 receptor in a murine IL-2-dependent cell line. Int. J. Immunopharmacol. 14, 583-593
29. Liao, W., Lin, J. X., and Leonard, W. J. (2013) Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13-25
30. Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R., and Farrar, M. A. (2007) IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3α regulatory T cells. J. Immunol. 178, 280-290
31. Yao, Z., Kanno, Y., Kerenyi, M., Stephens, G., Durant, L., Watford, W. T., Laurence, A., Robinson, G. W., Shevach, E. M., Moriggl, R., Hennighausen, L., Wu, C., and O'Shea, J. J. (2007) Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109, 4368-4375
32. Macauley, M. S., and Vocadlo, D. J. (2010) Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase. Biochim. Biophys. Acta 1800, 107-121
33. Jeon, J. H., Suh, H. N., Kim, M. O., Ryu, J. M., and Han, H. J. (2014) Glucosamine-induced OGT activation mediates glucose production through cleaved Notch1 and FoxO1, which coordinately contributed to the regulation of maintenance of self-renewal in mouse embryonic stem cells. Stem Cells and Development 23, 2067-2079
34. Golks, A., Tran, T. T., Goetschy, J. F., and Guerini, D. (2007) Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 26, 4368-4379
35. Ramakrishnan, P., Clark, P. M., Mason, D. E., Peters, E. C., Hsieh-Wilson, L. C., and Baltimore, D. (2013) Activation of the transcriptional function of the NF-αB protein c-Rel by O-GlcNAc glycosylation. Science Signaling 6, ra75
36. Jang, B. C., Sung, S. H., Park, J. G., Park, J. W., Bae, J. H., Shin, D. H., Park, G. Y., Han, S. B., and Suh, S. I. (2007) Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner. J. Biol. Chem. 282, 27622-27632
37. Wellen, K. E., Lu, C., Mancuso, A., Lemons, J. M., Ryczko, M., Dennis, J. W., Rabinowitz, J. D., Coller, H. A., and Thompson, C. B. (2010) The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev. 24, 2784-2799
38. Plagemann, P. G., and Erbe, J. (1973) Transport and metabolism of glucosamine by cultured Novikoff rat hepatoma cells and effects on nucleotide pools. Cancer Research 33, 482-492
39. Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., and Chi, H. (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367-1376
40. Macintyre, A. N., Gerriets, V. A., Nichols, A. G., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., and Rathmell, J. C. (2014) The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function. Cell Metabolism 20, 61-72
41. Asano, T., Katagiri, H., Takata, K., Lin, J. L., Ishihara, H., Inukai, K., Tsukuda, K., Kikuchi, M., Hirano, H., Yazaki, Y., and et al. (1991) The role of N-glycosylation of GLUT1 for glucose transport activity. J. Biol. Chem. 266, 24632-24636
42. Asano, T., Takata, K., Katagiri, H., Ishihara, H., Inukai, K., Anai, M., Hirano, H., Yazaki, Y., and Oka, Y. (1993) The role of N-glycosylation in the targeting and stability of GLUT1 glucose transporter. FEBS Lett. 324, 258-261
43. Delovitch, T. L., and Singh, B. (1997) The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7, 727-738
44. Bending, D., De la Peña, H., Veldhoen, M., Phillips, J. M., Uyttenhove, C., Stockinger, B., and Cooke, A. (2009) Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119, 565-572
45. Rabinovitch, A., Suarez-Pinzon, W. L., Sorensen, O., Bleackley, R. C., and Power, R. F. (1995) IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154, 4874-4882
46. Höglund, P., Mintern, J., Waltzinger, C., Heath, W., Benoist, C., and Mathis, D. (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189, 331-339
47. Gagnerault, M. C., Luan, J. J., Lotton, C., and Lepault, F. (2002) Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196, 369-377
48. Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., and Kuchroo, V. K. (2004) Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200, 79-87
49. Ivanov II, McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., and Littman, D. R. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 T helper cells. Cell 126, 1121-1133
50. Chesnokov, V., Gong, B., Sun, C., and Itakura, K. (2014) Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation. Cancer Cell International 14, 45
51. Yang, X. P., Ghoreschi, K., Steward-Tharp, S. M., Rodriguez-Canales, J., Zhu, J., Grainger, J. R., Hirahara, K., Sun, H. W., Wei, L., Vahedi, G., Kanno, Y., O'Shea, J. J., and Laurence, A. (2011) Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12, 247-254
52. Boehmelt, G., Wakeham, A., Elia, A., Sasaki, T., Plyte, S., Potter, J., Yang, Y., Tsang, E., Ruland, J., Iscove, N. N., Dennis, J. W., and Mak, T. W. (2000) Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. EMBO J. 19, 5092-5104
53. Kang, E. S., Han, D., Park, J., Kwak, T. K., Oh, M. A., Lee, S. A., Choi, S., Park, Z. Y., Kim, Y., and Lee, J. W. (2008) O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells. Exp. Cell Res. 314, 2238-2248
54. Suh, H. N., Lee, Y. J., Kim, M. O., Ryu, J. M., and Han, H. J. (2014) Glucosamine-induced Sp1 O-GlcNAcylation ameliorates hypoxia-induced SGLT dysfunction in primary cultured renal proximal tubule cells. J. Cell. Physiol. 229, 1557-1568
55. Nicoletti, F., Zaccone, P., Di Marco, R., Di Mauro, M., Magro, G., Grasso, S., Mughini, L., Meroni, P., and Garotta, G. (1996) The effects of a nonimmunogenic form of murine soluble interferon-α receptor on the development of autoimmune diabetes in the NOD mouse. Endocrinology 137, 5567-5575
56. Yang, X. D., Michie, S. A., Tisch, R., Karin, N., Steinman, L., and McDevitt, H. O. (1994) A predominant role of integrinα4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 91, 12604-12608
57. Mkhikian, H., Grigorian, A., Li, C. F., Chen, H. L., Newton, B., Zhou, R. W., Beeton, C., Torossian, S., Tatarian, G. G., Lee, S. U., Lau, K., Walker, E., Siminovitch, K. A., Chandy, K. G., Yu, Z., Dennis, J. W., and Demetriou, M. (2011) Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nature Communications 2, 334
58. Lee, S. U., Grigorian, A., Pawling, J., Chen, I. J., Gao, G., Mozaffar, T., McKerlie, C., and Demetriou, M. (2007) N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration. J. Biol. Chem. 282, 33725-33734
59. Quintana, F. J., Jin, H., Burns, E. J., Nadeau, M., Yeste, A., Kumar, D., Rangachari, M., Zhu, C., Xiao, S., Seavitt, J., Georgopoulos, K., and Kuchroo, V. K. (2012) Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat. Immunol. 13, 770-777
60. Hong, C., Luckey, M. A., Ligons, D. L., Waickman, A. T., Park, J. Y., Kim, G. Y., Keller, H. R., Etzensperger, R., Tai, X., Lazarevic, V., Feigenbaum, L., Catalfamo, M., Walsh, S. T., and Park, J. H. (2014) Activated T cells secrete an alternatively spliced form of commonβ-chain that inhibits cytokine signaling and exacerbates inflammation. Immunity 40, 910-923